Skip to content

Closure Techniques and Scar Appearance

A Randomized Prospective Trial of 2-Octyl Cyanoacrylate (Derma-Bond) Tissue Adhesive Versus Running Subcuticular Suture Combined With Tissue Adhesive Versus Epidermal Sutures in Dermatologic Surgery Procedures of the Head and Neck

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01352533
Enrollment
0
Registered
2011-05-12
Start date
2016-07-31
Completion date
2017-07-31
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Closure Techniques

Brief summary

The goal of this study is to assess whether wound closure with skin adhesive or running stitches combined with skin adhesive will be superior to standard wound sutures. This is a split-wound study that will compare two methods of skin closure within one standard closure technique, thereby providing an internal control of running stitches within each wound. The investigators plan to measure outcomes by assessing for scar appearance, the incidence of wound opening, scar elasticity and subject satisfaction.

Interventions

PROCEDURERunning polypropylene closure

Half of every wound will be closed with Standard of Care running polypropylene sutures

PROCEDURETissue Adhesive (Derma-Bond)

Approximately half of wounds will be randomized to be closed with tissue adhesive.

PROCEDURESubcuticular polyglactin-910 combined with tissue adhesive

Approximately half of the experimental wounds will be randomized to be closed with a combination of subcuticular polyglactin-910 and tissue adhesive.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 and over * Linear closures on the head and neck, at least 3cm in length * The subjects are in good health * The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.

Exclusion criteria

* Under 18 years of age * Pregnancy or Lactation * Subjects who are unable to understand the protocol or to give informed consent * Subjects with mental illness * Defects on the scalp

Design outcomes

Primary

MeasureTime frameDescription
Wound Healing10 day/3 weeks and 3 monthsThe primary outcome measure of this study will be wound healing. This outcome will be assessed by the blinded observers, subject ratings and Cutometer measurements of scar elasticity. Two double-blinded dermatologists will be asked to rate the scars according to the objective scar scales at the 10 day/ 3 week and 3 month follow-up exams.

Secondary

MeasureTime frameDescription
Dehiscence10 days/3 weeks and 3 monthsThe rate of dehiscence observed will be noted and recorded by the treating physicians.
Subject Satisfaction10 days/3 weeks and 3 monthsThe subjects will fill out the VAS to evaluate their overall assessment of their scar, any associated pruritus and pain. The subjects will also fill out a Subject Satisfaction Survey to evaluate subject preference for closure.
Adverse Events10 days/3 weeks and 3 monthsThe treating physicians will note occurrence and extent of any adverse events associated with either type of epidermal closure.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026